{"id":"metesculetol","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["metesculetol sodium","metesculetol"],"offLabel":[],"synonyms":["metesculetol sodium","metesculetol"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and METESCULETOL is a key that fits into those locks. When it binds to the right lock, it can turn on or off certain cellular processes to help treat a disease or condition. This is a simplified way of understanding how small molecule drugs like METESCULETOL work at a molecular level.","oneSentence":"METESCULETOL works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"METESCULETOL's mechanism of action is likely to involve reversible binding to a specific protein or receptor, leading to a downstream effect on cellular signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1724","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METESCULETOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:36:49.944678","biosimilars":[],"competitors":[],"genericName":"metesculetol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005377","UNII":"HO6I89Z64J","CHEBI":"CHEBI:135018","INN_ID":"261","UMLSCUI":"C0771448","ChEMBL_ID":"CHEMBL2105200","PUBCHEM_CID":"5390106","SECONDARY_CAS_RN":"53285-61-3"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"METESCULETOL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"METESCULETOL is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this drug's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}